Menu Search
Equities

Enseval Putera Megatrading Tbk PT

PTEPF:PNK

Enseval Putera Megatrading Tbk PT

Actions
  • Price (USD)0.00
  • Today's Change0.00 / 0.00%
  • Shares traded0.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Dec 30 1899.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

PT Enseval Putera Megatrading Tbk is an Indonesia-based integrated distribution and logistics service company in the health sector. The Company is engaged in the distribution and supply of pharmaceutical products, consumer products, medical equipment, cosmetics and other trading products. Its business activities include distribution and sales of consumer products; prescription medicines; non-prescription medicines; raw materials for sale; medical equipment; veterinary and livestock medicines, and health care and transportation services. It provides services across digital platforms, distribution and sales, health care, marketing and logistics. It offers a range of products, such as consumer products, prescription and non-prescription medicines, raw materials, medical devices, clinics and veterinary products. The Company and its subsidiaries own 71 branches throughout Indonesia from Banda Aceh to Jayapura, supported by infrastructure to assist the operation of logistics.

  • Revenue in IDR (TTM)28.51tn
  • Net income in IDR688.50bn
  • Incorporated1989
  • Employees5.12k
  • Location
    Enseval Putera Megatrading Tbk PTJl. Pulo Lentut No. 10Kawasan Industri Pulo GadungJAKARTA TIMUR 13920IndonesiaIDN
  • Phone+62 2 146822422
  • Fax+62 214609039
  • Websitehttps://www.enseval.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.